Head of Computational Biology
Philippe is currently the Head of the Computational Biology Department at GSK (GlaxoSmithKline). He is also the GSK lead for Open Targets an innovative pre-competitive collaboration located in Hinxton (UK) between the Sanger Centre, the EBI (European Bioinformatics Institute), GSK and Biogen. He serves on several academic advisory boards and funding panels in the UK and EU and has published more that 50 peer-reviewed scientific articles. Philippe has a PhD from University of Rennes in France. His post-doctoral training was at the Imperial Cancer Research Fund in London (now Cancer Research UK) with a focus on Immunogenetics.